Alphyn Biologics, Inc.

New JDD Research Paper Finds Few Atopic Dermatitis Topicals Treat Full Spectrum of Disease; Alphyn's Zabalafin Hydrogel Candidate Cited as Potential Multi-Target Option

Leading dermatologist authors note emerging evidence for Zabalafin's anti-inflammatory, anti-pruritic, anti-microbial and anti-xerotic effects…